FDA Grants Approval for Docosanol ANDA220017 by KLM Labs
The FDA has granted approval for the ANDA220017 application for Docosanol submitted by KLM Labs.
Therapeutic Area
Therapeutic area intelligence for Topical Antiviral with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.